Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Open to sponsorsSelectiveView FDAPMDA
SCALE 00 studies
Open to sponsorsSelectiveView Company states Integrated Drug Discovery services span "multiple therapeutic areas including but not limited to oncologyCNSmetabolic disorderspain & inflammation". Programme counts stated on the same page: Oncology 30+
SCALE 00 studies
Open to sponsorsGeneral clinicalView FDAPMDA
SCALE 00 studies
Open to sponsorsGeneral clinicalView SCALE 00 studies
Open to sponsorsGeneral clinicalView Company lists: Oncology & HematologyDermatologyNeuroscienceBiosimilar Development
SCALE 900 studies
Open to sponsorsGeneral clinicalView Company lists: OncologyFibrosisRespiratory DiseasesNeuroscience
SCALE 130 studies
Open to sponsorsGeneral clinicalView SCALE 00 studies
Not recordedNot recordedView Company states expertise across oncologycardiologynephrologyurology
SCALE 630 studies
Open to sponsorsGeneral clinicalView Company site lists OncologyDermatologyRespiratoryBiosimilars and Vaccines as therapeutic areas
SCALE 400 studies
Open to sponsorsGeneral clinicalView E
Guildford, United Kingdom · Europe
SCALE 00 studies
Not recordedNot recordedView SCALE 630 studies
Open to sponsorsGeneral clinicalView SCALE 00 studies
Not recordedNot recordedView London, United Kingdom · Europe
SCALE 00 studies
Not recordedNot recordedView PC
Zug, Switzerland · Europe
SCALE 00 studies
Not recordedNot recordedView Nottingham, United Kingdom · Europe
SCALE 200 studies
Open to sponsorsGeneral clinicalView Nijmegen, Netherlands · Europe
SCALE 130 studies
Open to sponsorsGeneral clinicalView Stated on the company's Who We Are page: "multiple therapeutic areas with a specific focus on Inflammation & PainInfectious DiseasesCentral Nervous systemsand Oncology".
SCALE 00 studies
Open to sponsorsGeneral clinicalView 
